ImmunoCellular Therapeutics IMUC
announced today that the Board of Directors has appointed John S. Yu, MD, as
Interim Chief Executive Officer and President, and has accepted the
resignation of Manish Singh, PhD, effective immediately, from the CEO,
President, and Board positions. Dr. Yu will continue to serve as Chief
Scientific Officer and Chairman of the Board. ImmunoCellular has initiated a
search for a permanent chief executive officer.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsManagement
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in